This platform offers standard in vitro experimentation procedures for the functional validation of candidate genes and biomarkers, and for the efficacy and toxicological evaluation of new drugs, biomaterials and biomarkers.
At the moment, the platform offers standardin vivo experimentation procedures for the evaluation of new therapeutic targets, nanotherapies and biomarkers in the field of oncology and rare diseases.
Next Monday, November 19, Vall d’Hebron will hold a seminar focused on Lysosomal Rare Disorders: Focus on Fabry Disease. The seminar is part of the Rare...Read more
Dr. Joan Genescà, head of the Liver Diseases research group and Dr. María Martell, group researcher and head of the Advanced Liver Disease laboratory, from the Liver...Read more
Nanomedicine & Bioengineering
Mendez O, Peg V, Salvans C, Pujals M, Fernandez Y, Abasolo I, Perez J, Matres A, Valeri M, Gregori J, Villarreal L, Schwartz S, Ramon Y Cajal S, Tabernero J, Cortes...Read more